SPECT/CT in Melanoma Lymphoscintigraphy

Tew, Khimling; Farlow, David

doi:10.1097/rlu.0000000000001407

Cited by 7 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SPECT/CT is a tomographic imaging technique using gamma rays that, unlike nuclear medicine planar imaging, provides true 3D information. This is particularly useful when the primary tumour is located on the patient's trunk, as the direction of lymphatic drainage is less predictable than that of an extremity [22]. Cancer cells only in top or outer layer of skin.…”

Section: Lymphoscintigraphymentioning

confidence: 99%

The Pathogenesis and Clinical Management of Cutaneous Melanoma: An Evidence-Based Review

Burns

George

Aucoin

et al. 2019

Journal of Medical Imaging and Radiation Sciences

View full text Add to dashboard Cite

Cutaneous malignant melanoma (CM) is the leading cause of skin cancer-related mortality and accounts for approximately 1,250 deaths in Canada each year. It is also one of few cancers continuing to display rates of increasing incidence throughout the world. The past decade has brought significant growth in our understanding of the pathogenesis and clinical management of CM. This evidencebased review synthesizes that knowledge, beginning with a review of the epidemiology and etiology of the disease followed by a broad review of the roles of diagnostic imaging in its management. Special attention is given to the role of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography-computed tomography (PET/CT) in supporting assessment at primary presentation of disease, follow-up to surgical and nonsurgical treatment, and for the surveillance of high-risk asymptomatic patients. After a brief review of current treatment options, this article concludes with a demonstration of how and when uncertainty exists at the point of care systematic review processes may be used to resolve clinical questions. Learning Objectives:By the end of this Continuing Medical Education article, participants will be able to 1. Describe the epidemiology and etiology of cutaneous melanoma, 2. Describe broadly the role of diagnostic imaging in the clinical management of cutaneous melanoma, 3. Describe the specific roles and limitations of 18 F-FDG PET/CT in the clinical management of cutaneous melanoma, 4. Describe broadly the best practice in the treatment of cutaneous melanoma, 5. Define the value of systematic review for synthesizing knowledge pertaining to a specific clinical question, and 6. Discuss the utility of 18 F FDG PET/CT in the management of early-stage (AJCC 0-IIc) cutaneous melanoma.This is a CME article and provides the equivalent of 2 hours of continuing education that may be applied to your professional development credit system. A 12-question multiple choice quiz follows this reading. Please note that no formalized credit (Category A) is available from CAMRT.

show abstract

Section: Lymphoscintigraphymentioning

confidence: 99%

The Pathogenesis and Clinical Management of Cutaneous Melanoma: An Evidence-Based Review

Burns

George

Aucoin

et al. 2019

Journal of Medical Imaging and Radiation Sciences

View full text Add to dashboard Cite

show abstract

“…Recently many case reports from different centers have been published in which SPECT-CT was used to verify the results of PL [26][27][28][29][30]. Also, several studies that evaluated the number of additional lymph nodes and the benefits of SPECT-CT imaging in the skin-melanoma population in different locations have been published.…”

Section: Originalmentioning

confidence: 99%